Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 7,648 shares at $38.59 ($295K) on 2024-01-05, disclosed to the SEC on 2024-01-09.
Open-market sale of $295k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.59 | 3,824 | $148K | 50.0% |
| 2 | $38.59 | 3,824 | $148K | 50.0% |
| Total | $38.59 avg | 7,648 | $295K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |